Hyperrab 300UNIT/ML 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FW9QL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,596
Award facts
- Contract value 100% obligated
- $6,596.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 7, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $6,596.40 to AmerisourceBergen Drug Corp for HYPERRAB 300 unit/ml immunoglobulin product. This firm fixed-price delivery order, which is not set-aside, is being performed at the contractor's Conshohocken, Pennsylvania location and is scheduled for completion by January 8, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical commodities—including specialty medications, brand-name and generic drugs, vaccines, and medical supplies—to support military healthcare programs worldwide. The contract supports critical federal customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key vendor in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FW9QL?
SPE2DR26FW9QL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FW9QL worth?
The government has obligated $6,596 on SPE2DR26FW9QL.
Is contract SPE2DR26FW9QL an order under another contract?
Yes. SPE2DR26FW9QL is a delivery order under SPE2DR25D7062, an indefinite delivery contract.
Was contract SPE2DR26FW9QL competed?
The extent of competition for SPE2DR26FW9QL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award